We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $748M
1-Year Est. Return 27.21%
This Fund
S&P 500
This Quarter Est. Return
+8.91%
1 Year Est. Return
+27.21%
3 Year Est. Return
+69.53%
5 Year Est. Return
+110.76%
10 Year Est. Return
–
AUM
$237M
AUM Growth
+$17.9M
Cap. Flow
+$325K
Cap. Flow %
0.14%
Top 10 Hldgs %
29.98%
Holding
77
New
4
Increased
27
Reduced
36
Closed
4

Top Buys

Rank Stock Value
1
NEU icon
NewMarket
NEU
+$588K
2
AMGN icon
Amgen
AMGN
+$557K
3
TJX icon
TJX Companies
TJX
+$494K
4
CNI icon
Canadian National Railway
CNI
+$386K
5
CLB icon
Core Laboratories
CLB
+$356K

Top Sells

Rank Stock Value
1
LMT icon
Lockheed Martin
LMT
+$790K
2
PII icon
Polaris
PII
+$626K
3
GILD icon
Gilead Sciences
GILD
+$563K
4
PG icon
Procter & Gamble
PG
+$457K
5
CLX icon
Clorox
CLX
+$299K

Sector Composition

Rank Sector Weight
1 Healthcare 21.42%
2 Technology 18.18%
3 Consumer Discretionary 17.52%
4 Industrials 16.8%
5 Consumer Staples 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$187B
$8.72M 3.68%
138,732
-9,421
-6% -$563K
MA icon
2
Mastercard
MA
$507B
$8.08M 3.41%
120,170
+2,480
+2% +$156K
ORCL icon
3
Oracle
ORCL
$457B
$7.45M 3.14%
224,569
+2,592
+1% +$84.1K
AME icon
4
Ametek
AME
$54.5B
$7.24M 3.05%
157,411
-2,794
-2% -$126K
MKC icon
5
McCormick & Company Non-Voting
MKC
$14B
$7.12M 3%
220,244
-280
-0.1% -$9.82K
PII icon
6
Polaris
PII
$3.56B
$6.75M 2.84%
52,222
-5,573
-10% -$626K
CTSH icon
7
Cognizant
CTSH
$28.1B
$6.61M 2.79%
161,040
+6,950
+5% +$258K
GGG icon
8
Graco
GGG
$12.6B
$6.58M 2.78%
266,766
-2,616
-1% -$61.5K
ACN icon
9
Accenture
ACN
$114B
$6.48M 2.73%
87,987
+543
+0.6% +$40.2K
MSFT icon
10
Microsoft
MSFT
$3.71T
$6.06M 2.55%
181,994
+2,964
+2% +$97.5K
APH icon
11
Amphenol
APH
$204B
$6.05M 2.55%
1,250,608
+10,144
+0.8% +$49.5K
PEP icon
12
PepsiCo
PEP
$188B
$5.94M 2.5%
74,679
+410
+0.6% +$33.7K
NEU icon
13
NewMarket
NEU
$8.14B
$5.89M 2.48%
20,458
+2,118
+12% +$588K
NKE icon
14
Nike
NKE
$57B
$5.67M 2.39%
156,188
-1,384
-0.9% -$45.2K
ROST icon
15
Ross Stores
ROST
$73.7B
$5.61M 2.37%
154,146
-2,360
-2% -$80.5K
ROL icon
16
Rollins
ROL
$17.3B
$5.17M 2.18%
657,656
-3,577
-0.5% -$27.4K
OA
17
DELISTED
Orbital ATK, Inc.
OA
$5.06M 2.13%
51,834
-285
-0.5% -$27K
VAR
18
DELISTED
Varian Medical Systems, Inc.
VAR
$4.99M 2.1%
76,128
+334
+0.4% +$21.2K
SEIC icon
19
SEI Investments
SEIC
$13.2B
$4.98M 2.1%
161,224
-2,720
-2% -$83.8K
SYK icon
20
Stryker
SYK
$116B
$4.97M 2.1%
73,564
-20
-0% -$1.38K
AAPL icon
21
Apple
AAPL
$4.67T
$4.94M 2.08%
290,192
+12,544
+5% +$208K
TTC icon
22
Toro Company
TTC
$8.83B
$4.88M 2.06%
179,710
+4,850
+3% +$123K
EV
23
DELISTED
Eaton Vance Corp.
EV
$4.71M 1.98%
121,198
-930
-0.8% -$37K
BCR
24
DELISTED
CR Bard Inc.
BCR
$4.64M 1.96%
40,278
-306
-0.8% -$35.1K
OXY icon
25
Occidental Petroleum
OXY
$60B
$4.52M 1.91%
50,476
-3,189
-6% -$274K
1
2 3 4

Similar funds

VCM
Virtue Capital Management Brentwood, Tennessee $749M AUM 40.13% 1-Year Est. Return
QI
Qtron Investments Boston, Massachusetts $750M AUM 44.01% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
BCM
Bienville Capital Management New York $750M AUM 2.59% 1-Year Est. Return
BG
BDF Gestion Paris, France $747M AUM 47.35% 1-Year Est. Return
PCM
Permanent Capital Management Chicago, Illinois $747M AUM 17.94% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

JLB & Associates's Q3 2013 Portfolio in Review

As of Q3 2013, JLB & Associates held 77 positions worth $237M, up 8.2% from $219M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

JLB & Associates's Q3 2013 filing shows 4 new, 27 increased, 36 reduced and 4 closed positions. Its largest new stake was Core Laboratories: 2,295 shares worth $388K. The largest sale was Lockheed Martin, an estimated $790K.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • JLB & Associates's largest Q3 2013 buy was Core Laboratories: 2,295 shares worth $388K.
  • JLB & Associates added most to NewMarket in Q3 2013, an estimated $588K increase.
  • JLB & Associates's biggest Q3 2013 reduction was Polaris, cutting an estimated $626K.
  • JLB & Associates fully exited Lockheed Martin in Q3 2013, selling an estimated $790K.
  • JLB & Associates's ten largest holdings make up 30% of its $237M portfolio in Q3 2013.
  • JLB & Associates opened 4 new positions and closed 4 in Q3 2013.
  • JLB & Associates's portfolio value rose 8.2% quarter-over-quarter to $237M.

Based on JLB & Associates's 13F filing for Q3 2013, filed 7 Oct 2013.